A Look at the Innovations Introduced by the 2014 FOYA Category Winners
The 2014 Facility of the Year Awards program is shaping up to be one of the most noteworthy events of the year. A few weeks ago, we talked about what the pharmaceutical and biopharmaceutical industry can learn from the facilities recognized by FOYA. Category Winners have been announced and this year’s winning projects showcase some amazing innovations.
The category winners are:
Boehringer Ingelheim Pharma GmbH & Co. KG: Winner of the Facility of the Year Award for Equipment Innovation
F. Hoffmann-La Roche: Winner of the Facility of the Year Award for Sustainability
Grifols Therapeutics, Inc.: Winner of the Facility of the Year Award for Project Execution
Patheon Pharma Services (formerly DSM Biologics): Winner of the Facility of the Year Award for Process Innovation
Penn Pharmaceutical Services Ltd.: Winner of the Facility of the Year Award for Facility Integration
Pfizer Ireland Pharmaceuticals: Winner of the Facility of the Year Award for Operational Excellence
The FOYA Judging Panel also chose to award an Honorable Mention to WuXi AppTec Biopharmaceutical for their recently completed flexible CGMP bulk cell culture production facility. The facility, consisting of two parallel upstream cell culture bioreactor lines with flexible working volumes of 50l through 2,000l bioreactors and one downstream purification production line is the most advanced such facility built in the People’s Republic of China.
Pharmaceutical Engineering is introducing a new part of the Pharmaceutical Engineering Online site: Online Exclusives. This content will be published only to the ISPE web site—it will not be published in print. Read on for FAQs about this new feature,...
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from February 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last...
As we continue to monitor the COVID-19 pandemic, our thoughts are with our Members and those impacted. We recognize that the ever-changing impact of this novel virus is disruptive to so many aspects of our personal and professional lives. We are not...